ロード中...
Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
INTRODUCTION: Psoriasis is an immune-mediated inflammatory skin disorder, which follows a chronic course. Apremilast is a novel phosphodiesterase 4 (PDE4) inhibitor, approved by US-FDA for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. A majority of the data related to...
保存先:
| 出版年: | Indian J Dermatol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer - Medknow
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640799/ https://ncbi.nlm.nih.gov/pubmed/33165422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_194_19 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|